CVS and UnitedHealth lost ground on Medicare ratings. Who gained? By Investing.com RSS CTA
Humana (HUM) gained 16.5% after its Medicare Advantage plan improved to four stars, restoring federal bonus eligibility. Analysts expect $4.8B in bonuses in 2028. UnitedHealth (UNH) and CVS (CVS) saw declines in four-star-plus plan memberships. Humana's 2027 EPS is projected to rebound to $17.31 after a 47% drop in 2026.
How this was made
The 30-second read
Why it matters
Higher star ratings increase federal quality bonus payouts, directly affecting earnings forecasts for insurers.
Market read
The new star ratings create immediate price moves for major MA insurers, with Humana rallying and UnitedHealth/CVS under pressure.
What to watch
Potential policy changes to Medicare Advantage funding and competitive pressure from new entrants.
Background
The federal government released its 2027 Medicare Advantage Star Ratings, reshaping bonus eligibility for insurers.
Ticker impact
Humana surged 16.5% after its flagship Medicare Advantage plan rose to a four‑star rating in the new 2027 Star Ratings.
upward pressure as the market prices in the bonus‑payment outlook
The four‑star rating directly increases eligibility for federal quality bonuses, a $4.8 bn upside, and analysts have upgraded the stock.
UnitedHealth Group is projected to fall to 67% of members in four‑star‑plus plans, down from 81%, per the new Star Ratings.
potential downside as investors reassess future bonus payments
The rating downgrade suggests reduced federal bonus eligibility, which could hurt earnings outlook.
CVS Health is expected to drop to 70% of members in four‑star‑plus plans, down from 84%, according to the new ratings.
slight downside as bonus‑payment forecasts are trimmed
The decline in four‑star‑plus membership share signals less federal quality bonus revenue.
Market effects
Medicare Advantage sector may see re‑rating driven reallocations, benefiting higher‑rated insurers.
U.S. healthcare stocks could experience divergent moves based on rating outcomes.
Limited to U.S. insurers; no direct global impact.
Counterpoint
The rating boost may be temporary; cost pressures and benefit‑ratio rises could offset bonus gains.
Key entities
- CompanyHumana
Second‑largest Medicare Advantage insurer, benefitting from a four‑star rating.
- CompanyUnitedHealth Group
Largest Medicare Advantage insurer, facing a downgrade in star rating.
- CompanyCVS Health
Pharmacy‑health conglomerate, also seeing a rating decline.
